Literature DB >> 35834071

A joint PCR-based gene-targeting method using electroporation in the pathogenic fungus Trichosporon asahii.

Yasuhiko Matsumoto1, Tae Nagamachi2, Asami Yoshikawa2, Tsuyoshi Yamada3,4, Takashi Sugita2.   

Abstract

Trichosporon asahii is a pathogenic fungus that causes deep-seated fungal infections in immunocompromised patients. Established methods for generating gene-deficient T. asahii mutants exist, but the frequency of obtaining transformants by electroporation remains low. In the present study, we optimized the conditions for gene transfer by electroporation using a ku70 gene-deficient mutant with high recombination efficiency. Introducing a DNA fragment by electroporation into T. asahii cells on Sabouraud dextrose agar to generate a cnb1 gene-deficient mutant and incubating for 1 day led to the growth of approximately 100 transformants. When the incubation period was extended to 2 days or 5 days, however, only 2 or no transformants, respectively, were grown. The highest number of transformants was grown by electroporation when a square wave at 1.8 kV (9 kV/cm) was applied for 5 ms. In addition, the number of transformants increased with an increase in the length of the homologous region, and transformants did not grow when the homologous region was less than 500 base pairs. A DNA fragment was produced for deletion of the cnb1 gene by joint PCR, and the cnb1 gene-deficient mutant was obtained by introducing the DNA fragment by electroporation. These results indicate that DNA fragments produced by joint PCR can be used to generate gene-deficient mutants of T. asahii through gene transfer by electroporation.
© 2022. The Author(s).

Entities:  

Keywords:  Electroporation; Gene targeting; Joint PCR; Mutant; Trichosporon asahii

Year:  2022        PMID: 35834071      PMCID: PMC9283638          DOI: 10.1186/s13568-022-01431-9

Source DB:  PubMed          Journal:  AMB Express        ISSN: 2191-0855            Impact factor:   4.126


Introduction

Trichosporon asahii is a basidiomycete yeast that is widely distributed in the environment and isolated from human blood, sputum, skin, feces, and urine (Sugita et al. 2001; Zhang et al. 2011; Colombo et al. 2011; Gouba et al. 2014; Cho et al. 2015). T. asahii is a pathogenic fungus that causes severe deep-seated fungal infections in neutropenic patients (Walsh et al. 1992, 1993; de Almeida Júnior and Hennequin 2016; Duarte-Oliveira et al. 2017). While the mortality rate of deep-seated mycosis caused by Candida albicans is approximately 40%, that caused by T. asahii is approximately 80% (Krcmery et al. 1999; Girmenia et al. 2005). T. asahii is resistant to echinocandin antifungals, and infectious diseases caused by T. asahii often occur in the patients treated with micafungin (Goodman et al. 2002; Kimura et al. 2018, 2022). Moreover, T. asahii strains resistant to antifungals such as amphotericin B and fluconazole have been isolated from patients (Toriumi et al. 2002; Iturrieta-González et al. 2014). Therefore, revealing the infection mechanisms and drug-resistant systems of T. asahii is crucial. Phenotypic analyses using gene-deficient mutants are important for clarifying the molecular mechanisms of infection and drug resistance in T. asahii. We established a method for generating a gene-deficient mutant of T. asahii using an Agrobacterium tumefaciens-mediated gene transfer system (Matsumoto et al. 2021). The efficiency of genetic recombination in T. asahii was increased by deleting the ku70 gene that encodes the Ku70 protein, a subunit of the non-homologous end-joining repair enzyme (Matsumoto et al. 2021). The ku70 gene-deficient mutant exhibited the same proliferative ability in vitro and the same virulence in a silkworm infection model as the wild strain of T. asahii (Matsumoto et al. 2021). Therefore, the ku70 gene-deficient mutant of T. asahii is useful as a parental strain for generating gene-deficient mutants by homologous recombination. The development of simple methods for generating gene-deficient mutants requires the optimization of gene transfer methods and improved construction of gene-targeting plasmids. For deletion of a target gene by homologous recombination, a DNA fragment containing the 5'-UTR and 3'-UTR of the target gene is necessary. The DNA fragment can be produced by joint PCR without cloning using Escherichia coli (Yu et al. 2004). A method for producing a gene-deficient mutant of Cryptococcus neoformans, a closely related species of T. asahii, was established using a DNA fragment produced by joint PCR (Lin et al. 2015). The DNA fragment used for deletion of the target gene is amplified by PCR and introduced into T. asahii by electroporation. When the ku70 gene-deficient mutant of T. asahii is used as the parent strain, however, the number of transformants obtained by electroporation is less than 10 (Matsumoto et al. 2021). In the present study, we optimized the electroporation conditions for gene transfer into T. asahii. A gene-deficient mutant was generated using a DNA fragment produced by joint PCR under optimized conditions. Our findings suggest that a gene-deficient mutant of T. asahii can be efficiently generated by electroporation without gene cloning using E. coli.

Materials and methods

Reagents

Nourseothricin and G418 were purchased from Jena Bioscience (Dortmund, Germany) and Enzo Life Science, Inc. (Farmingdale, NY, USA), respectively.

Culture of T. asahii

The T. asahii strain (MPU129 ku70 gene-deficient mutant) used in this study was generated as previously reported (Matsumoto et al. 2021). The strain have been deposited in MPU culture collection. The T. asahii MPU129 ku70 gene-deficient mutant was grown on Sabouraud dextrose agar (SDA) containing G418 (50 μg/ml) and incubated at 27 °C for 2 days.

Preparing competent T. asahii cells

Competent T. asahii cells were prepared according to a previous report with slight modification (Matsumoto et al. 2021). The T. asahii MPU129 ku70 gene-deficient mutant was spread on SDA and incubated at 27 °C for 1, 2, or 5 days. T. asahii cells on the agar were suspended in physiologic saline solution (2 ml), and the suspension was transferred to a 1.5 ml tube. The fungal cells were collected by centrifugation at 8000 rpm for 3 min (TOMY-MX100, TOMY Digital Biology Co. Ltd, Tokyo, Japan) and suspended by adding 1 ml of ice-cold water and centrifuged at 8000 rpm for 3 min. This washing process was repeated four times. The washed cells were suspended by adding 1 ml of 1.2 M sorbitol solution and centrifuged at 8000 rpm for 3 min. The obtained fungal cells were suspended with 0.2 ml of 1.2 M sorbitol solution as competent cells.

Electroporation

Electroporation was performed according to a previous report with slight modification (Matsumoto et al. 2021). The PCR-amplified 5'-UTR (cnb1) -NAT1-3'-UTR (cnb1) fragment (180 ng/2 µl) was added to the competent T. asahii cells (40 µl) and placed on ice for 15 min. The suspension was added to a 0.2 cm gap cuvette (Bio-Rad Laboratories, Inc.) and electroporated (time constant protocol: 1.8 kV, 5 ms) using a Gene Pulser Xcell (Bio-Rad Laboratories, Inc.). The cells were suspended by adding 500 µl YPD containing 0.6 M sorbitol and incubated at 27 °C for 3 h. After incubation, the cells were collected by centrifugation at 10,000 rpm for 5 min, suspended in 100 µl of physiologic saline solution, and applied to SDA containing nourseothricin (300 µg/ml). The cells were incubated at 27 °C for 3 days, and the growing colonies were isolated as cnb1 gene-deficient mutant candidates.

Genotyping PCR

Genotyping PCR was performed according to a previous report with slight modification (Matsumoto et al. 2021). The transformants were grown on SDA containing nourseothricin (300 µg/ml). Colony PCR was performed using Primers-2 for cnb1 genotyping (Table 1). The genome of transformants selected by the colony PCR was extracted using a Quick-DNA™ Fungal/Bacterial Miniprep Kit (Zymo Research, Irvine, CA, USA). The mutation of the genome of the transformants was confirmed by PCR using the primers shown in Table 1.
Table 1

Primers used in this study

PrimersNucleic acid sequence
[Amplification of cnb1 cassette]
2000 bp
Fcnb1(2000 bp)CCGTGATCTGCTGCACGTTCGGGTCCG
Rcnb1(2000 bp)CTGTTCACCTCTGGCTACGACCCCCTCCTC
1500 bp
Fcnb1(1500 bp)ACGAGCCTTGCGCTGGGCCTCCT
Rcnb1(1500 bp)GCTCCTGCCGGTGGCTACGAGCAGCC
1000 bp
Fcnb1(1000 bp)CATTGCCGCCAACCTTGAGTGCTCGGAGC
Rcnb1(1000 bp)GCCGCGCCCCCGCCAGCCGGGAAAC
500 bp
Fcnb1(500 bp)CGCGCCGCGCTGTCCCATCGCTATTACAC
Rcnb1(500 bp)CATACCCGCCCCTTTCCTATGTGACTGATACC
250 bp
Fcnb1(250 bp)CTGCGTTGGAGGACACGTCTACTCGCCATGA
Rcnb1(250 bp)ACATGTCATGATGTTCATGGAAGGGGAAGAG
[Joint PCR]
cnb1(5ʹUTR)
Fcnb1(5ʹUTR)ACGAGCCTTGCGCTGGGCCTCCT
Rcnb1(5ʹUTR)(NAT1 inf)AGCTCACATCCTCGCAGCGCAGTGCAATCTTGGTCAGTCGGTCGTGGCC
cnb1(3ʹUTR)
Fcnb1(3ʹUTR)(NAT1 inf)TAGTTTCTACATCTCTTCGCGCGCACACACGGATGTGAGCGTAACGAG
Rcnb1(3ʹUTR)GCTCCTGCCGGTGGCTACGAGCAGCC
NAT1
FNAT1(5ʹUTR inf)TGACCAAGATTGCACTGCGCTGCGAGGATGTGAGCTGGAGAGC
RNAT1(3ʹUTR inf)ACATCCGTGTGTGCGCGCGAAGAGATGTAGAAACTAGCTTCCTGGTTTC
cnb1(5ʹUTR)-NAT1
Fcnb1(5ʹUTR)ACGAGCCTTGCGCTGGGCCTCCT
RNAT1(3ʹUTR inf)ACATCCGTGTGTGCGCGCGAAGAGATGTAGAAACTAGCTTCCTGGTTTC
NAT1- cnb1(3ʹUTR)
FNAT1(5ʹUTR inf)TGACCAAGATTGCACTGCGCTGCGAGGATGTGAGCTGGAGAGC
Rcnb1(3ʹUTR)GCTCCTGCCGGTGGCTACGAGCAGCC
cnb1(5ʹUTR)-NAT1-cnb1(3ʹUTR)
Fcnb1(5ʹUTR)ACGAGCCTTGCGCTGGGCCTCCT
Rcnb1(3ʹUTR)GCTCCTGCCGGTGGCTACGAGCAGCC
[Genotyping]
Primers-1 for cnb1 genotyping
F cnb1 gene locusGGAGTGAAGAAGGGCAGAGAGCAACAACAGCGGT
R cnb1 gene locusCCGTGATCGCATGGGGCGTGCACAAAGTG
Primers-2 for cnb1 genotyping
F cnb1 gene ORFCGGCTCGGGTACGGTAGACTTCCAGGAGTTTGTCG
R cnb1 gene ORFAACAGGTCCTCGAGCGTCATCTGCTTGACGATGT
Primers used in this study

Amplification of DNA fragments by joint PCR

Joint PCR was performed according to a previous report with slight modification (Lin et al. 2015). The genome of T. asahii MPU129 strain was used as a template to amplify the 5′-UTR (cnb1) and 3′-UTR (cnb1), and the previously generated 5'-UTR (cnb1)-NAT1-3'-UTR (cnb1) was used as a template to amplify the NAT1 gene (1st PCR). Double-joint PCR was performed using the PCR products obtained by the 1st PCR to amplify 5'-UTR(cnb1)-NAT1 and NAT1-3'-UTR(cnb1) (2nd PCR). The 5'-UTR (cnb1)-NAT1-3'-UTR (cnb1) was amplified by double-joint PCR using the PCR product obtained by 2nd PCR (3rd PCR).

Results

Optimization of electroporation conditions for the introduction of DNA fragments into T. asahii

In this study, we used a DNA fragment containing the 5'-UTR, the 3'-UTR of the cnb1 gene, and the NAT1 gene, a nourseothricin resistance gene (Fig. 1A). Increasing the gene transfer efficiency is necessary to optimize the conditions for the preparation of competent cells and electroporation (Fig. 1B). Proliferative phase cells often have higher competency than stationary phase cells and are used as competent cells for gene transfer in yeast (McGlincy et al. 2021). T. asahii cells were spread on SDA and incubated for 1, 2, or 5 days, respectively, and collected to prepare competent cells. When a DNA fragment was introduced by electroporation into a competent cell that had been cultured for 1 day to generate a cnb1 gene-deficient mutant, approximately 100 colonies grew on SDA containing nourseothricin (Fig. 1C). On the other hand, only 2 colonies grew when the incubation period was 2 days, and no colonies were observed when the incubation period was 5 days (Fig. 1C). This finding suggests that the competency of T. asahii is decreased by longer incubation.
Fig. 1

Optimization of the conditions for gene transfer by electroporation in T. asahii. A Structure of the DNA fragment for constructing the cnb1 gene-deficient mutant and the predicted genome of the cnb1 gene-deficient mutant. B Scheme for obtaining drug-resistant strains by gene transfer via electroporation. C Effect of the number of incubation days for preparing competent T. asahii cells. The T. asahii MPU129 ku70 gene-deficient mutant was spread on SDA and incubated at 27 °C for 1, 2, or 5 days. The PCR-amplified 5'-UTR (cnb1) -NAT1-3'-UTR (cnb1) fragment (180 ng/2 µl) was added to the competent T. asahii cells (40 µl) and electroporated (time constant protocol: 1.8 kV, 5 ms). The number of colonies grown on SDA containing nourseothricin (300 µg/ml) was counted. D Effect of voltage on gene transfer by electroporation. The PCR-amplified 5'-UTR (cnb1) -NAT1-3'-UTR (cnb1) fragment (180 ng/2 µl) was added to competent T. asahii cells (40 µl) prepared by culture for 1 day and electroporated (time constant protocol: 1.2–2.1 kV, 5 ms). The number of colonies grown on SDA containing nourseothricin (300 µg/ml) was counted. E Effect of time constant on gene transfer by electroporation. The PCR-amplified 5'-UTR (cnb1) -NAT1-3'-UTR (cnb1) fragment (180 ng/2 µl) was added to competent T. asahii cells (40 µl) prepared by culture for 1 day and electroporated (time constant protocol: 1.8 kV, 3–10 ms). The number of colonies grown on SDA containing nourseothricin (300 µg/ml) was counted

Optimization of the conditions for gene transfer by electroporation in T. asahii. A Structure of the DNA fragment for constructing the cnb1 gene-deficient mutant and the predicted genome of the cnb1 gene-deficient mutant. B Scheme for obtaining drug-resistant strains by gene transfer via electroporation. C Effect of the number of incubation days for preparing competent T. asahii cells. The T. asahii MPU129 ku70 gene-deficient mutant was spread on SDA and incubated at 27 °C for 1, 2, or 5 days. The PCR-amplified 5'-UTR (cnb1) -NAT1-3'-UTR (cnb1) fragment (180 ng/2 µl) was added to the competent T. asahii cells (40 µl) and electroporated (time constant protocol: 1.8 kV, 5 ms). The number of colonies grown on SDA containing nourseothricin (300 µg/ml) was counted. D Effect of voltage on gene transfer by electroporation. The PCR-amplified 5'-UTR (cnb1) -NAT1-3'-UTR (cnb1) fragment (180 ng/2 µl) was added to competent T. asahii cells (40 µl) prepared by culture for 1 day and electroporated (time constant protocol: 1.2–2.1 kV, 5 ms). The number of colonies grown on SDA containing nourseothricin (300 µg/ml) was counted. E Effect of time constant on gene transfer by electroporation. The PCR-amplified 5'-UTR (cnb1) -NAT1-3'-UTR (cnb1) fragment (180 ng/2 µl) was added to competent T. asahii cells (40 µl) prepared by culture for 1 day and electroporated (time constant protocol: 1.8 kV, 3–10 ms). The number of colonies grown on SDA containing nourseothricin (300 µg/ml) was counted Next, we optimized the electroporation conditions. Approximately 120 colonies were grown on SDA containing nourseothricin at 1.8 kV (Fig. 1D). In the other conditions, the number of colonies was lower than when the voltage was 1.8 kV (Fig. 1D). The highest number of colonies grew on SDA containing nourseothricin when the time constant was 5 ms (Fig. 1E). These results suggest that 1.8 kV (9 kV/cm) for 5 ms is the optimal condition for electroporation to introduce DNA fragments into the T. asahii MPU129 ku70 gene-deficient mutant. More than 500 base pairs of homologous regions are required for gene deletion by double crossover in the filamentous fungi (Yu et al. 2004). On the other hand, DNA fragments, including longer homologous regions, are difficult to produce by joint PCR. We then examined the effect of the length of the homologous region on the efficiency of genetic recombination in T. asahii. DNA fragments with different lengths of homologous regions were amplified by PCR (Fig. 2A, B). The number of colonies grown on SDA containing nourseothricin increased as the length of the homologous region increased (Fig. 2C). Colonies did not grow on SDA containing nourseothricin when the homologous region was less than 500 bp (Fig. 2C). The results suggest that a homologous region longer than 1500 bp enhanced the efficiency of gene transfer into the T. asahii cells.
Fig. 2

Effect of the length of homologous regions for gene transfer by electroporation in T. asahii. A Illustration of DNA fragments used in this study. B Electrophoresis of DNA fragments amplified by PCR. C The PCR-amplified 5ʹ-UTR (cnb1) -NAT1-3ʹ-UTR (cnb1) fragments were added to the competent T. asahii cells prepared by culture for 1 day and electroporated (time constant protocol: 1.8 kV, 5 ms). The number of colonies grown on SDA containing nourseothricin (300 µg/ml) was counted

Effect of the length of homologous regions for gene transfer by electroporation in T. asahii. A Illustration of DNA fragments used in this study. B Electrophoresis of DNA fragments amplified by PCR. C The PCR-amplified 5ʹ-UTR (cnb1) -NAT1-3ʹ-UTR (cnb1) fragments were added to the competent T. asahii cells prepared by culture for 1 day and electroporated (time constant protocol: 1.8 kV, 5 ms). The number of colonies grown on SDA containing nourseothricin (300 µg/ml) was counted Next, we examined the optimal concentration of DNA fragments for electroporation. When competent cells were electroporated with DNA fragment 2 having a homologous region of 1500 bp, more than 80 colonies grew at 3.4 and 6.8 nM (Fig. 3). In other conditions, the number of colonies was less than 30 (Fig. 3). These results suggest that a DNA fragment concentration of approximately 3.4–6.8 nM is optimal for gene transfer by electroporation.
Fig. 3

Effect of the DNA concentration for gene transfer by electroporation in T. asahii. The DNA fragment 2 (0–13.5 nM) was added to competent T. asahii cells prepared by culture for 1 day and electroporated (time constant protocol: 1.8 kV, 5 ms). The number of colonies grown on SDA containing nourseothricin (300 µg/ml) was counted

Effect of the DNA concentration for gene transfer by electroporation in T. asahii. The DNA fragment 2 (0–13.5 nM) was added to competent T. asahii cells prepared by culture for 1 day and electroporated (time constant protocol: 1.8 kV, 5 ms). The number of colonies grown on SDA containing nourseothricin (300 µg/ml) was counted

Generation of a gene-deficient mutant using DNA fragments produced by joint PCR

Joint PCR is useful for obtaining DNA fragments without cloning in E. coli (Yu et al. 2004). We examined whether a cnb1 gene-deficient mutant could be obtained using DNA fragments produced by joint PCR. Each joint PCR step amplified DNA fragments with the predicted size, and a DNA fragment for generating the cnb1 gene-deficient mutant was obtained (Fig. 4). Nourseothricin-resistant strains were obtained by introducing the DNA fragment into T. asahii by electroporation, which was optimized in this study. Among the 45 nourseothricin-resistant strains, 8 strains were deficient for the cnb1 gene (Fig. 5, Table 2). These results suggest that the cnb1 gene-deficient mutants of T. asahii were generated using DNA fragments amplified by joint PCR.
Fig. 4

Construction of DNA fragment for gene targeting by joint PCR. Scheme of constructing DNA fragments for gene targeting by joint PCR to generate cnb1 gene-deficient mutants and electrophoresis of DNA fragments amplified by PCR or joint PCR

Fig. 5

Generation of cnb1 gene-deficient mutant using DNA fragment produced by joint PCR. A DNA fragment 2 produced by joint PCR was added to competent T. asahii cells prepared by culture for 1 day and electroporated (time constant protocol: 1.8 kV, 5 ms). Colony PCR was performed on colonies (samples 1–15) grown on SDA containing nourseothricin (300 µg/ml). B Location of the primers for confirming the genome structure of the cnb1 gene-deficient candidate by PCR. C Confirmation of the cnb1 gene-deficiency of the cnb1 gene-deficient candidate by PCR using extracted genome DNA

Table 2

Efficiency of homologous replacement in cnb1 gene region

DNA fragmentLength of homologous regions (bp)Total transformantsHomologous replacement(∆cnb1)Efficiency (%)(∆cnb1/total transformants)
Joint PCR product150045818%
DNA fragment 1a200021419%

aData are cited from Matsumoto et al.(Matsumoto et al. 2021)

Construction of DNA fragment for gene targeting by joint PCR. Scheme of constructing DNA fragments for gene targeting by joint PCR to generate cnb1 gene-deficient mutants and electrophoresis of DNA fragments amplified by PCR or joint PCR Generation of cnb1 gene-deficient mutant using DNA fragment produced by joint PCR. A DNA fragment 2 produced by joint PCR was added to competent T. asahii cells prepared by culture for 1 day and electroporated (time constant protocol: 1.8 kV, 5 ms). Colony PCR was performed on colonies (samples 1–15) grown on SDA containing nourseothricin (300 µg/ml). B Location of the primers for confirming the genome structure of the cnb1 gene-deficient candidate by PCR. C Confirmation of the cnb1 gene-deficiency of the cnb1 gene-deficient candidate by PCR using extracted genome DNA Efficiency of homologous replacement in cnb1 gene region aData are cited from Matsumoto et al.(Matsumoto et al. 2021)

Discussion

Here, we developed a method to establish a cnb1 gene-deficient mutant of T. asahii using PCR-amplified DNA fragments without gene cloning in E. coli. Using this method, it is theoretically possible to obtain a gene-deficient mutant of T. asahii within 1 week. Further experiments are needed to determine whether strains deficient in other genes can be obtained under these experimental conditions. Optimizing the preparation of competent cells and electroporation conditions is very important for improving gene transfer (Edman and Kwon-Chung 1990; Wang 2018). The transformants in this study were obtained by introducing a drug-resistant gene via homologous recombination and non-homologous end-joining repair. In a previous study, we used competent cells cultured for 2–3 days, and the number of transformants obtained was less than 10 (Matsumoto et al. 2021). Competent cells incubated for 1 day had higher competency than those incubated for 2 days. For generating gene-deficient mutants by electroporation, longer homologous regions should be used to increase the recombination efficiency (Ueno et al. 2007). On the other hand, the use of long DNA fragments decreased the gene transfer efficiency (Lamichhane et al. 2015). Moreover, long DNA fragments are difficult to produce by joint PCR (Bryksin and Matsumura 2010). Therefore, optimizing the length of the homologous regions is important toward increasing the efficiency of obtaining gene-deficient mutants. In T. asahii, a 1500-bp homologous region is needed to obtain gene-deficient mutant candidates by electroporation at a ratio of approximately 20%. The efficiency of homologous replacement in the cnb1 gene region by joint PCR products in this study is similar to that in a previous study in which PCR products were amplified using a purified targeting plasmid (Matsumoto et al. 2021). Therefore, joint PCR products are useful for generating gene-deficient mutants in T. asahii by gene transfer via electroporation. A DNA fragment amplified by joint PCR for deletion of a target gene can be used to generate cnb1 gene-deficient mutants in T. asahii. This method enabled us to produce DNA fragments for the deletion of target genes more rapidly and conveniently than the conventional method of producing DNA fragments using E. coli. In a future study, we will generate gene-deficient mutants of T. asahii established in this study and analyze their pathogenicity functions. In conclusion, we established a simple method for generating gene-deficient mutants in T. asahii via electroporation. The method might contribute to uncovering the molecular mechanisms of infection and drug resistance in T. asahii.
  25 in total

1.  Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.

Authors:  Muneyoshi Kimura; Hideki Araoka; Hisashi Yamamoto; Shigeki Nakamura; Minoru Nagi; Satoshi Yamagoe; Yoshitsugu Miyazaki; Sho Ogura; Takashi Mitsuki; Mitsuhiro Yuasa; Daisuke Kaji; Kosei Kageyama; Aya Nishida; Yuki Taya; Hiroshi Shimazu; Kazuya Ishiwata; Shinsuke Takagi; Go Yamamoto; Yuki Asano-Mori; Naoyuki Uchida; Atsushi Wake; Shuichi Taniguchi; Akiko Yoneyama
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

2.  Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation.

Authors:  J C Edman; K J Kwon-Chung
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

3.  Overlap extension PCR cloning: a simple and reliable way to create recombinant plasmids.

Authors:  Anton V Bryksin; Ichiro Matsumura
Journal:  Biotechniques       Date:  2010-06       Impact factor: 1.993

4.  Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis.

Authors:  T J Walsh; J W Lee; G P Melcher; E Navarro; J Bacher; D Callender; K D Reed; T Wu; G Lopez-Berestein; P A Pizzo
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

5.  Development of a highly efficient gene targeting system induced by transient repression of YKU80 expression in Candida glabrata.

Authors:  Keigo Ueno; Jun Uno; Hironobu Nakayama; Kaname Sasamoto; Yuzuru Mikami; Hiroji Chibana
Journal:  Eukaryot Cell       Date:  2007-05-18

Review 6.  Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen.

Authors:  João N de Almeida Júnior; Christophe Hennequin
Journal:  Front Microbiol       Date:  2016-10-17       Impact factor: 5.640

7.  A genome-scale CRISPR interference guide library enables comprehensive phenotypic profiling in yeast.

Authors:  Nicholas J McGlincy; Zuriah A Meacham; Kendra K Reynaud; Ryan Muller; Rachel Baum; Nicholas T Ingolia
Journal:  BMC Genomics       Date:  2021-03-23       Impact factor: 3.969

Review 8.  The Cell Biology of the Trichosporon-Host Interaction.

Authors:  Cláudio Duarte-Oliveira; Fernando Rodrigues; Samuel M Gonçalves; Gustavo H Goldman; Agostinho Carvalho; Cristina Cunha
Journal:  Front Cell Infect Microbiol       Date:  2017-04-07       Impact factor: 5.293

9.  Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.

Authors:  Ping Wang
Journal:  mSphere       Date:  2018-06-13       Impact factor: 4.389

10.  Development of an efficient gene-targeting system for elucidating infection mechanisms of the fungal pathogen Trichosporon asahii.

Authors:  Yasuhiko Matsumoto; Tae Nagamachi; Asami Yoshikawa; Hideki Yamazaki; Yusuke Yamasaki; Tsuyoshi Yamada; Takashi Sugita
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.